Celixir Company

Tissue specific regenerative medicine products, progenitor cells, phase 2 clinical trials. Devoted to discovering breakthrough medicines that change the standard of medical care for patients.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 2009
Employees Number: 11-50
Funding Status: M&A
Investors Number: 1
Total Funding: $2.6M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership